Laphare SRL
Laphare reported total assets of 49,090 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Laphare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -13 % Total assets +25 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Laphare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 27 May 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 06 Jun 2023
- Year ended 31 Dec 2021filed on 23 Jun 2022
Laphare's financial analysis
- Solvency52.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Laphare
Laphare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0662.775.858
- VAT number
- BE0662775858
- Peppol
- Registered · 0208:0662775858 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2016
- Registered office
- 5640 Mettet
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Laphare (SRL) has been based in Mettet since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 1,659 € and equity of 25,601 €; its revenue is not published. Its solvency stands at 52.2%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Laphare
Companies in the same business, of comparable size and area, outside its group.
- Bossiroy Pharma Retail sale of pharmaceutical products Uccle · balance sheet 65,695 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- Verhuizen Anke BV Retail sale of pharmaceutical products Vorselaar · balance sheet 27,853 €
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- OKINEO System Retail sale of pharmaceutical products Colfontaine · balance sheet 64,459 €
- NS Drone Projects Retail sale of medical and orthopaedic goods Lendelede · balance sheet 766 €
Frequently asked questions about Laphare
What is the revenue of Laphare?
Laphare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Laphare?
In Belgium, the VAT number is the company number prefixed with BE: BE0662775858 for Laphare, if the company is VAT-registered. Its company number (CBE) is 0662.775.858.
Where is the registered office of Laphare?
According to the CBE register, the registered office of Laphare is in 5640 Mettet.
What is the equity of Laphare?
At the close of the 2025 financial year, the equity of Laphare amounts to 25,601 €, a solvency of 52.2% of total assets.
Who manages Laphare?
The register lists 1 active mandates at Laphare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Laphare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →